Arthrosi Therapeutics
Arthrosi Therapeutics develops pharmaceutical treatments centered on gout and related conditions through clinical research and drug development programs. The company advances its investigational oral therapy designed to lower uric acid, address gout flares, and reduce hard crystal deposits in joint tissue by progressing it through late-stage clinical studies. Its work includes conducting randomized controlled trials to gather data on the therapeutic effects and safety profile of its lead compound in diverse patient groups. Arthrosi Therapeutics also engages in regulatory and scientific activities to support potential future approvals and collaborations. The organization communicates progress through published trial milestones and industry announcements.
Domain
arthrosi.com
Country
United StatesIndustry
BiotechnologyEmployees
11-50
Last Funding
$153.0M
Founded
2017
Tech Stack (1 technologies)
Frequently Asked Questions
What technologies does Arthrosi Therapeutics use?+
Arthrosi Therapeutics uses 1 technologies including Nginx.
What industry is Arthrosi Therapeutics in?+
Arthrosi Therapeutics operates in the Biotechnology industry.
Where is Arthrosi Therapeutics based?+
Arthrosi Therapeutics is headquartered in United States.
Need this data at scale?
Get ready-to-use datasets: companies, technologies, and tech adoption signals across 3M+ websites.
Browse DatasetsData last updated: June 2026